Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix.
about
Erythropoietin or darbepoetin for patients with cancerCombined use of hyperthermia and radiation therapy for treating locally advanced cervix carcinomaErythropoietin or Darbepoetin for patients with cancer - meta-analysis based on individual patient dataCombined use of hyperthermia and radiation therapy for treating locally advanced cervical carcinomaErythropoietin or Darbepoetin for patients with cancer - meta-analysis based on individual patient dataCombined use of hyperthermia and radiation therapy for treating locally advanced cervical cancerErythropoietin for patients with malignant diseaseErythropoietin or Darbepoetin for patients with cancerRegulation of protein synthesis by hypoxia via activation of the endoplasmic reticulum kinase PERK and phosphorylation of the translation initiation factor eIF2alpha.Hypoxia and oxidative stress in breast cancer. Hypoxia signalling pathwaysKinetic analysis of dynamic 18F-fluoromisonidazole PET correlates with radiation treatment outcome in head-and-neck cancerPathophysiological Basis for the Formation of the Tumor MicroenvironmentImaging tumour hypoxia with positron emission tomographyImaging tumor hypoxia to advance radiation oncologyThe clinical importance of assessing tumor hypoxia: relationship of tumor hypoxia to prognosis and therapeutic opportunitiesHypoxia and VEGF mRNA expression in human tumorsExpression pattern of the urokinase-plasminogen activator system in rat DS-sarcoma: role of oxygenation status and tumour sizeTargeting hypoxia to overcome radiation resistance in head & neck cancers: real challenge or clinical fairytale?In vivo photoacoustic lifetime imaging of tumor hypoxia in small animals.The effects of hyperoxic and hypercarbic gases on tumour blood flow.Imaging biomarkers in primary brain tumours.Dose escalation to combat hypoxia in prostate cancer: a radiobiological study on clinical data.Repetitive tissue pO2 measurements by electron paramagnetic resonance oximetry: current status and future potential for experimental and clinical studiesUsing Stable Free Radicals to Obtain Unique and Clinically Useful Data In Vivo in Human Subjects.Disparate responses of tumour vessels to angiotensin II: tumour volume-dependent effects on perfusion and oxygenation.Blood flow and oxygenation status of human tumors. Clinical investigations.Localized hypothermia: impact on oxygenation, microregional perfusion, metabolic and bioenergetic status of subcutaneous rat tumoursMultiparameter analysis of vasculature, perfusion and proliferation in human tumour xenografts.Noninvasive molecular imaging of hypoxia in human xenografts: comparing hypoxia-induced gene expression with endogenous and exogenous hypoxia markers.Trityl-based EPR probe with enhanced sensitivity to oxygen.GLUT1 gene is a potential hypoxic marker in colorectal cancer patients.Expression of HIF-1alpha and VEGF in colorectal cancer: association with clinical outcomes and prognostic implicationsPharmacokinetic analysis of hypoxia (18)F-fluoromisonidazole dynamic PET in head and neck cancer.Molecular mechanisms of hypoxia in cancer.PET radiopharmaceuticals for imaging of tumor hypoxia: a review of the evidenceThe radiation response of cells from 9L gliosarcoma tumours is correlated with [F18]-EF5 uptakeRegulation of p53 by hypoxia: dissociation of transcriptional repression and apoptosis from p53-dependent transactivation.Biodistribution and dosimetry of (18)F-EF5 in cancer patients with preliminary comparison of (18)F-EF5 uptake versus EF5 binding in human glioblastomaAcute versus chronic hypoxia in tumors: Controversial data concerning time frames and biological consequences.Hypoxia links ATR and p53 through replication arrest.
P2860
Q24202335-5EDE863A-3164-4CF0-AD58-F41412C17DCCQ24236810-C7700C27-4453-4DE2-BFB6-9C1A89CD339FQ24240202-A4658BBC-7FF1-4C1F-AE22-80B218EA9A84Q24240468-EF917BF8-5059-4C7F-94BD-B91734396757Q24242864-3262C411-EBCF-4ED5-89B7-9399C7C85DE1Q24243735-A4A73DFF-D9BE-4588-8AEA-9CFAC567C0B2Q24245427-35364E7D-395C-4D32-B9B2-F8C366347998Q24245464-E895339A-665F-4556-86B5-38B4BBFE3AAAQ24540258-96E91931-F2B0-4ADB-B66F-80C0703DE3B2Q24801701-2231341E-E023-4E6E-B605-24B66F5EF62BQ25256988-F6515243-165F-4966-BDC2-D75273621532Q26752406-4C448AF6-3439-45D8-BF9A-63BEC07858A4Q26851422-940486AD-A88B-4A36-BB60-A5A18D084008Q27007862-559C46A8-7C1A-4309-8F03-D2F39A34C5EEQ27025579-C43948F8-1FE8-443A-8A83-EA41153E5762Q28344471-4115B47C-824F-4EC6-9304-2B568ED75291Q28565213-5B4EF261-BBF9-41DA-B601-08F788138B31Q30388849-1749DD78-2D65-45CD-A397-33B05A2BDF54Q30434454-2FE34C1C-8CF6-478F-81B3-6AF2FD4C5C85Q30632172-23A34377-6C37-4581-BF8A-CEB42F3656DAQ30880129-3B60AB46-EB3F-4FAA-B5DB-068A060B4DD8Q31051243-574DB00F-FAFC-49BC-8357-91D27FA9C876Q31114143-04F76032-3D82-47F4-A44E-BDB2E581214DQ31144718-CD6E9B28-B1CC-4849-B8E0-9258F903F496Q31791086-635AE690-794A-415A-BF9B-BB733EB296CCQ31913190-A6E5215B-C2AB-410A-AF48-131934BCEA73Q32054825-32ACFFD0-8476-4902-9891-E12A6A8ED530Q32127388-2E9D85DF-C7AC-454B-84ED-9F60BE9D2536Q33376948-30388F58-F7C8-41E2-A275-0DA9C4156425Q33442855-BC3E5F59-7C46-44AA-8E65-D5C4140BDB83Q33484365-67120237-FF2B-4DE9-8EC8-FD90586F6030Q33517893-FC418186-06A6-4403-BC61-9040B9CF0A48Q33688715-F2243F86-F2F1-4731-99D7-A2DAE90A9635Q33705108-DFCD4AD7-41A8-40FD-BCCD-DBFE630E89DCQ33818999-6B1DA7ED-ACA9-4D04-A96C-6AEB3393CAC0Q33949625-141B8906-CF60-4984-BC84-61417DE64CB9Q34011633-236125B4-CA1B-44BB-8DE0-267CC5938A4EQ34168711-6758F948-E05A-4D69-9A6B-2768956F352AQ34210210-DAE648DD-82EE-45EB-BB38-2D05C1BE4BA0Q34324309-DDB55D89-1FFD-479A-A50E-28113E25AF41
P2860
Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix.
@en
Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix.
@nl
type
label
Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix.
@en
Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix.
@nl
prefLabel
Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix.
@en
Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix.
@nl
P2093
P1476
Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix.
@en
P2093
Baussmann E
Knapstein PG
Schlenger K
Vorndran B
P356
10.1016/0167-8140(93)90025-4
P577
1993-01-01T00:00:00Z